US Moderna vaccine reveals immunity in adolescents

WASHINGTON, May 25 (KUNA) – The US Moderna agency introduced on Tuesday the success of its COVID-19 vaccine trials on adolescents. The trials have been carried out on greater than 3,600 youngsters ageD 12 to 17, and it confirmed constructive responses towards the virus. “We will submit these outcomes to the US FDA and regulators globally in early June and request authorization. We stay dedicated to doing our half to assist finish the COVID-19 pandemic, ”mentioned the agency in a press release.
If licensed, the vaccine would change into the second out there for adolescents as younger as 12. Pfizer-BioNTech’s vaccine was licensed for that age group earlier this month.

The put up US Moderna vaccine reveals immunity in adolescents appeared first on ARAB TIMES – KUWAIT NEWS.

Leave a Reply

Your email address will not be published. Required fields are marked *